Recalls and Safety Alerts: Avandia and Diabetic Macular Edema
Published by Food and Drug Adminstration (FDA): Patient Safety February 28th, 2006 in Patient Safety, Regulatory Affairs
Glaxo SmithKline has notified health professionals about reports of diabetic macular edema in patients receiving Avandia (rosiglitazone maleate) which is used to treat type 2 diabetes. These reports involved both new cases of macular edema and worsen...
Recalls and Safety Alerts: Avandia and Diabetic Macular Edema
Published by Food and Drug Adminstration (FDA): Patient Safety February 28th, 2006 in Patient Safety, Regulatory AffairsGlaxo SmithKline has notified health professionals about reports of diabetic macular edema in patients receiving Avandia (rosiglitazone maleate) which is used to treat type 2 diabetes. These reports involved both new cases of macular edema and worsen…
Recalls and Safety Alerts: Avandia and Diabetic Macular Edema
Published by Food and Drug Adminstration (FDA): Patient Safety February 28th, 2006 in Patient Safety, Regulatory Affairs
Glaxo SmithKline has notified health professionals about reports of diabetic macular edema in patients receiving Avandia (rosiglitazone maleate) which is used to treat type 2 diabetes. These reports involved both new cases of macular edema and worsen...